Tenax Therapeutics: 'Hold' TNX-103 Data August 2026 - But With Caution Ahead

Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...
JEC Composites

Toho Tenax develops energy-saving, high-productivity carbonizing process and surface treatment technologies

Toho Tenax Co., Ltd., the core company of the Teijin Group’s carbon fibers and composites business, announced that it has developed technologies for innovative microwave carbonization and plasma ...
TMCnet

Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary ...
WRIC

Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary ...

provide U.S. intellectual property (IP) protection until December 2040, and may qualify for additional U.S. patent term extension (PTE) beyond 2040 broaden IP protection for oral (TNX-103), IV, and ...
Oklahoma's News

Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary ...

Once granted, this patent will provide intellectual property protection until December 2040, and may qualify for additional U.S. patent term extension beyond 2040 There are currently no FDA approved ...
JEC Composites

Teijin’s Tenax carbon fiber prepreg adopted for next-generation aircraft engine nacelle

The Tenax™ prepreg used for the nacelle part was developed especially for aircraft applications using high-performance and rapid-curing epoxy resin. Notably, the Tenax™ prepreg can be molded at a ...